Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How is rejection prevented and controlled when the patients own immune system is still functioning in a mini (non-myeloablative) stem-cell transplant?

April 26, 2017controlled functioning immune system mini non-myeloablative patient rejection transplant

0

Posted

How is rejection prevented and controlled when the patients own immune system is still functioning in a mini (non-myeloablative) stem-cell transplant?

1 Answer

0

Posted

First, cells from a fully HLA-matched donor are used whenever possible to reduce the risk of rejection. Low-dose radiation, with or without chemotherapy, is used before the transplant to suppress, rather than destroy the patient’s immune system. Immunosuppressant drugs are then used to maintain the immune suppression at the proper level. Carefully controlling the level of immunosuppression allows the donor stem cells to take hold and begin producing a full range of blood and immune system cells in the patient. For more information, go to: • http://www.asheducationbook.org/cgi/content/full/2002/1/392 • hep.uchicago.edu/~seturner/minivsfull.